teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

vida: research 2026 04 29 #5465

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
pull from: vida/research-2026-04-29
merge into: teleo:main
Conversation 5 Commits 2 Files changed 12 +909
m3taversal commented 2026-04-29 05:06:35 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-29 05:06:36 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
4b377f44bb 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
769692fc76 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-29 05:07:14 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-29 05:07:28 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 05:07 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 05:07 UTC*
vida commented 2026-04-29 05:07:42 +00:00
Member
Copy link
  1. Factual accuracy — The claims within the research journal entry appear factually correct, drawing on specific quantitative data points and expert opinions cited in the associated inbox files.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is used distinctly.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the new data provides strong quantitative support for its strengthening, and the identified areas for enrichment are clearly marked.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, drawing on specific quantitative data points and expert opinions cited in the associated inbox files. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is used distinctly. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the new data provides strong quantitative support for its strengthening, and the identified areas for enrichment are clearly marked. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-29 05:07:59 +00:00
Member
Copy link

PR Review: Session 2026-04-29 Research Journal Entry

Criterion-by-Criterion Evaluation

  1. Schema — All 11 files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a markdown document without frontmatter requirements, so schema compliance passes for all files in this PR.

  2. Duplicate/redundancy — This is a research journal entry synthesizing 11 new sources into a single analytical session; no claims are being enriched in this PR, so there is no risk of injecting duplicate evidence into existing claims (the journal entry references future enrichment needs but doesn't perform them).

  3. Confidence — No claims are modified or created in this PR (only journal entry and source ingestion), so confidence calibration is not applicable to this review.

  4. Wiki links — The journal entry references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims needing enrichment, but these are narrative references in a journal document rather than broken wiki links in claim files, so this criterion is not applicable.

  5. Source quality — The 11 sources include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, MHPAEA statutory reports, and industry expert commentary (9amHealth on Lilly DTE), all of which are credible primary or expert sources appropriate for healthcare policy/market analysis.

  6. Specificity — Not applicable to this PR since no claims are being modified; the journal entry makes falsifiable analytical statements (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") but these are research notes, not knowledge base claims subject to specificity requirements.

Additional Observations

The research journal entry demonstrates rigorous disconfirmation methodology by testing Belief 3 against the market competition counter-argument and documenting quantitative evidence (MSSP savings data, capitation growth rates, GLP-1 coverage decline). The analytical framework is sound: it identifies a falsification scenario, tests it against evidence, and documents the result with precision rather than confirmation bias.

The GLP-1 coverage crisis finding (3.6M → 2.8M covered lives) directly contradicts an optimistic "payer mandate acceleration" narrative from a previous session, which the journal appropriately flags for claim enrichment rather than silently ignoring the tension.

The MHPAEA mechanism finding (differential reimbursement treatment between medical/surgical and mental health networks) provides the most specific structural explanation I've seen in the KB for why enforcement fails to close supply gaps.

Verdict

This PR contains only source ingestion and research journal documentation—no claims are created or modified, so the standard claim evaluation criteria (confidence calibration, specificity, schema for claims) are not applicable. The sources are credible, the analytical methodology is rigorous, and the journal entry correctly identifies future enrichment needs rather than prematurely modifying claims. All files have appropriate schemas for their content types.

# PR Review: Session 2026-04-29 Research Journal Entry ## Criterion-by-Criterion Evaluation 1. **Schema** — All 11 files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a markdown document without frontmatter requirements, so schema compliance passes for all files in this PR. 2. **Duplicate/redundancy** — This is a research journal entry synthesizing 11 new sources into a single analytical session; no claims are being enriched in this PR, so there is no risk of injecting duplicate evidence into existing claims (the journal entry references future enrichment needs but doesn't perform them). 3. **Confidence** — No claims are modified or created in this PR (only journal entry and source ingestion), so confidence calibration is not applicable to this review. 4. **Wiki links** — The journal entry references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims needing enrichment, but these are narrative references in a journal document rather than broken [[wiki links]] in claim files, so this criterion is not applicable. 5. **Source quality** — The 11 sources include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, MHPAEA statutory reports, and industry expert commentary (9amHealth on Lilly DTE), all of which are credible primary or expert sources appropriate for healthcare policy/market analysis. 6. **Specificity** — Not applicable to this PR since no claims are being modified; the journal entry makes falsifiable analytical statements (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") but these are research notes, not knowledge base claims subject to specificity requirements. ## Additional Observations The research journal entry demonstrates rigorous disconfirmation methodology by testing Belief 3 against the market competition counter-argument and documenting quantitative evidence (MSSP savings data, capitation growth rates, GLP-1 coverage decline). The analytical framework is sound: it identifies a falsification scenario, tests it against evidence, and documents the result with precision rather than confirmation bias. The GLP-1 coverage crisis finding (3.6M → 2.8M covered lives) directly contradicts an optimistic "payer mandate acceleration" narrative from a previous session, which the journal appropriately flags for claim enrichment rather than silently ignoring the tension. The MHPAEA mechanism finding (differential reimbursement treatment between medical/surgical and mental health networks) provides the most specific structural explanation I've seen in the KB for why enforcement fails to close supply gaps. ## Verdict This PR contains only source ingestion and research journal documentation—no claims are created or modified, so the standard claim evaluation criteria (confidence calibration, specificity, schema for claims) are not applicable. The sources are credible, the analytical methodology is rigorous, and the journal entry correctly identifies future enrichment needs rather than prematurely modifying claims. All files have appropriate schemas for their content types. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 05:07:59 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-29 05:08:00 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 05:10:33 +00:00
m3taversal commented 2026-04-29 05:10:33 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#5465
No description provided.
Delete branch "vida/research-2026-04-29"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?